| Style | Citing Format |
|---|---|
| MLA | Safarpour AR, et al.. "Reply to Biologics Are Effective in the Management of Inflammatory Bowel Disease Following Liver Transplantation in Combination With Antirejection Therapy." Inflammatory Bowel Diseases, vol. 28, no. 12, 2022, pp. E153-. |
| APA | Safarpour AR, Shojaeizarghani S, Mehrabi M, Keshtkar AA, Oroojan AA, Sivandzadeh GR (2022). Reply to Biologics Are Effective in the Management of Inflammatory Bowel Disease Following Liver Transplantation in Combination With Antirejection Therapy. Inflammatory Bowel Diseases, 28(12), E153-. |
| Chicago | Safarpour AR, Shojaeizarghani S, Mehrabi M, Keshtkar AA, Oroojan AA, Sivandzadeh GR. "Reply to Biologics Are Effective in the Management of Inflammatory Bowel Disease Following Liver Transplantation in Combination With Antirejection Therapy." Inflammatory Bowel Diseases 28, no. 12 (2022): E153-. |
| Harvard | Safarpour AR et al. (2022) 'Reply to Biologics Are Effective in the Management of Inflammatory Bowel Disease Following Liver Transplantation in Combination With Antirejection Therapy', Inflammatory Bowel Diseases, 28(12), pp. E153-. |
| Vancouver | Safarpour AR, Shojaeizarghani S, Mehrabi M, Keshtkar AA, Oroojan AA, Sivandzadeh GR. Reply to Biologics Are Effective in the Management of Inflammatory Bowel Disease Following Liver Transplantation in Combination With Antirejection Therapy. Inflammatory Bowel Diseases. 2022;28(12):E153-. |
| BibTex | @article{ author = {Safarpour AR and Shojaeizarghani S and Mehrabi M and Keshtkar AA and Oroojan AA and Sivandzadeh GR}, title = {Reply to Biologics Are Effective in the Management of Inflammatory Bowel Disease Following Liver Transplantation in Combination With Antirejection Therapy}, journal = {Inflammatory Bowel Diseases}, volume = {28}, number = {12}, pages = {E153-}, year = {2022} } |
| RIS | TY - JOUR AU - Safarpour AR AU - Shojaeizarghani S AU - Mehrabi M AU - Keshtkar AA AU - Oroojan AA AU - Sivandzadeh GR TI - Reply to Biologics Are Effective in the Management of Inflammatory Bowel Disease Following Liver Transplantation in Combination With Antirejection Therapy JO - Inflammatory Bowel Diseases VL - 28 IS - 12 SP - E153 EP - PY - 2022 ER - |